Human prion diseases: progress in clinical trials

Inga Zerr¹

Affiliations

Comment

Inga Zerr. Brain. 2013 Apr.

. 2013 Apr;136(Pt 4):996-7.

doi: 10.1093/brain/awt075.

Inga Zerr¹

¹ Department of Neurology, University Medical School, Georg-August University, Goettingen, Germany. epicjd@med.uni-goettingen.de

No abstract available

Comment on

The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies.
Thompson AG, Lowe J, Fox Z, Lukic A, Porter MC, Ford L, Gorham M, Gopalakrishnan GS, Rudge P, Walker AS, Collinge J, Mead S. Thompson AG, et al. Brain. 2013 Apr;136(Pt 4):1116-27. doi: 10.1093/brain/awt048. Brain. 2013. PMID: 23550114

1. Braaten AJ, Parsons TD, McCue R, Sellers A, Burns WJ. Neurocognitive differential diagnosis of dementing disease: Alzheimer's dementia, vascular dementia, frontotemporal dementia, and major depressive disorder. Int J Neurosci. 2006;116:1271–93. - PubMed
1. Heinemann U, Krasnianski A, Meissner B, Varges D, Bartl M, Stoeck K, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130:1350–9. - PubMed
1. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64:1586–91. - PubMed
1. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46:224–33. - PubMed
1. Pocchiari M, Poupolo M, Croes EA, Budka H, Gelpi E, Collins S, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004;10:2348–59. - PubMed